Thousands of Chlorthalidone BP Pills Recalled Over Dissolution Failures

The FDA is recalling about 11,400 bottles of the 25 mg diuretic chlorthalidone after testing showed some lots failed dissolution specifications, potentially reducing effectiveness. The tablets were made by Inventia Healthcare Limited (Mumbai) and distributed nationwide by Rising Pharma Holdings; affected products include 100-count (NDC 64980-599-01, batch RISA24001, exp. 04/2027) and 1,000-count (NDC 64980-599-10, batch RISB24002, exp. 04/2027) bottles. The recall is Class II (moderate hazard), and the FDA has not issued patient-specific instructions yet; patients should check their labels and consult a doctor or pharmacist if they have recalled tablets.